NDC 72855-100

Rivastigmine Transdermal System

Rivastigmine

Rivastigmine Transdermal System is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Adhexpharma. The primary component is Rivastigmine.

Product ID72855-100_9a24f3b3-120d-d793-e053-2a95a90a9ee2
NDC72855-100
Product TypeHuman Prescription Drug
Proprietary NameRivastigmine Transdermal System
Generic NameRivastigmine
Dosage FormPatch, Extended Release
Route of AdministrationTRANSDERMAL
Marketing Start Date2019-12-19
Marketing CategoryANDA / ANDA
Application NumberANDA209063
Labeler NameAdhexpharma
Substance NameRIVASTIGMINE
Active Ingredient Strength5 mg/24h
Pharm ClassesCholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72855-100-01

30 POUCH in 1 CARTON (72855-100-01) > 1 PATCH in 1 POUCH (72855-100-02) > 24 h in 1 PATCH
Marketing Start Date2019-12-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72855-100-01 [72855010001]

Rivastigmine Transdermal System PATCH, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA209063
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-19

NDC 72855-100-02 [72855010002]

Rivastigmine Transdermal System PATCH, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA209063
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-19

Drug Details

Active Ingredients

IngredientStrength
RIVASTIGMINE4.6 mg/24h

OpenFDA Data

SPL SET ID:9a250350-9e85-b152-e053-2a95a90ab97d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 725021
  • 725023
  • 1308569

    • Pharmacological Class

    • Cholinesterase Inhibitor [EPC]
    • Cholinesterase Inhibitors [MoA]

    NDC Crossover Matching brand name "Rivastigmine Transdermal System" or generic name "Rivastigmine"

    NDCBrand NameGeneric Name
    47781-305Rivastigmine Transdermal SystemRivastigmine Transdermal System
    47781-304Rivastigmine Transdermal SystemRivastigmine Transdermal System
    47781-405Rivastigmine Transdermal SystemRivastigmine Transdermal System
    51991-897Rivastigmine Transdermal SystemRivastigmine Transdermal System
    51991-899Rivastigmine Transdermal SystemRivastigmine Transdermal System
    51991-898Rivastigmine Transdermal SystemRivastigmine Transdermal System
    72855-102Rivastigmine Transdermal SystemRivastigmine Transdermal System
    72855-100Rivastigmine Transdermal SystemRivastigmine Transdermal System
    72855-101Rivastigmine Transdermal SystemRivastigmine Transdermal System
    63629-2066Rivastigmine Transdermal SystemRivastigmine Transdermal System
    63629-2065Rivastigmine Transdermal SystemRivastigmine Transdermal System
    63629-2064Rivastigmine Transdermal SystemRivastigmine Transdermal System
    0078-0501Exelonrivastigmine
    0078-0502Exelonrivastigmine
    0078-0503Exelonrivastigmine
    0378-9070Rivastigminerivastigmine
    0378-9071Rivastigminerivastigmine
    0378-9072Rivastigminerivastigmine
    0781-7304Rivastigminerivastigmine
    0781-7309Rivastigminerivastigmine
    0781-7313Rivastigminerivastigmine
    16714-115RivastigmineRivastigmine
    16714-116RivastigmineRivastigmine
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.